Papers

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

^a Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

Correspondence to: Professor Kiberd, 5077 RC Dickson Building, Victoria General Hospital, Halifax, Nova Scotia, Canada B3H 2Y9.

Abstract

Objective: To examine the conditions necessary to make screening for microalbuminuria in patients with insulin dependent diabetes mellitus cost effective.
Design: This economic evaluation compared two strategies designed to prevent the development of end stage renal disease in patients with insulin dependent diabetes with disease for five years. Strategy A, screening for microalbuminuria as currently recommended, was compared with strategy B, a protocol in which patients were screened for hypertension and macroproteinuria.
Intervention: Patients identified in both strategies were treated with an angiotensin converting enzyme inhibitor.
Setting: Computer simulation.
Main outcome measures: Strategy costs and quality adjusted life years (QALYs).
Results: The model predicted that strategy A would produce an additional 0.00967 QALYs at a present value cost of $261.53 (1990 US$) per patient (or an incremental cost/QALY of $27041.69) over strategy B. The incremental cost/QALY for strategy A over B was sensitive to several variables. If the positive predictive value of screening for microalbuminuria (impact of false label and unnecessary treatment) is <0.72, the effect of treatment to delay progression from microalbuminuria to macroproteinuria is <1.6 years, the cumulative incidence of diabetic nephropathy falls to <20%, or >64% of patients demonstrate hypertension at the onset of microalbuminuria, then the incremental costs/QALY will exceed $75000.
Conclusions: Whether microalbuminuria surveillance in this population is cost effective requires more information. Being aware of the costs, recommendation pitfalls, and gaps in our knowledge should help focus our efforts to provide cost effective care to this population.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Delea, T. E., Sofrygin, O., Palmer, J. L., Lau, H., Munk, V. C., Sung, J., Charney, A., Parving, H.-H., Sullivan, S. D. (2009). Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria. J. Am. Soc. Nephrol. 20: 2205-2213 [Abstract] [Full text]  
• Palmer, A. J., Valentine, W. J., Chen, R., Mehin, N., Gabriel, S., Bregman, B., Rodby, R. A. (2008). A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol Dial Transplant 23: 1216-1223 [Abstract] [Full text]  
• Jaar, B. G., Khatib, R., Plantinga, L., Boulware, L. E., Powe, N. R. (2008). Principles of Screening for Chronic Kidney Disease. CJASN 3: 601-609 [Full text]  
• Baskar, V., Kamalakannan, D., Kiberd, B., Holland, M.R., Singh, B.M. (2005). Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes. QJM 98: 427-433 [Abstract] [Full text]  
• Boulware, L. E., Jaar, B. G., Tarver-Carr, M. E., Brancati, F. L., Powe, N. R. (2003). Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis. JAMA 290: 3101-3114 [Abstract] [Full text]  
• Coffey, J. T., Brandle, M., Zhou, H., Marriott, D., Burke, R., Tabaei, B. P., Engelgau, M. M., Kaplan, R. M., Herman, W. H. (2002). Valuing Health-Related Quality of Life in Diabetes. Diabetes Care 25: 2238-2243 [Abstract] [Full text]  
• Murakami, Y., Ohashi, Y. (2001). Projected number of diabetic renal disease patients among insulin-dependent diabetes mellitus children in Japan using a Markov model with probabilistic sensitivity analysis. Int J Epidemiol 30: 1078-1083 [Abstract] [Full text]  
• Kiberd, B. A, Jindal, K. K (1996). Authors' reply. BMJ 312: 1421-1421 [Full text]  
• Borch-Johnsen, K., Mogensen, C. E., Ebbehoj, E., Wenzel, H., Viberti, G. (1996). Screening to prevent renal failure in diabetic patients. BMJ 312: 1420a-1420 [Full text]  
• Duncan, K., Baker, P. N, Johnson, I. R, Gowland, P. (1996). Treat patients with kindness during magnetic resonance imaging. BMJ 312: 1421b-1421 [Full text]  
• (1996). SCREENING DIABETICS FOR MICROALBUMINURIA: HOW COST- EFFECTIVE?. JWatch General 1996: 5-5 [Full text]